Hospira, Inc. - Product Pipeline Review - 2015

  • ID: 3440679
  • Company Profile
  • 39 pages
  • Global Markets Direct
1 of 4
Hospira, Inc. - Product Pipeline Review - 2015

Summary

The report ‘Hospira, Inc. - Product Pipeline Review - 2015’, provides an overview of the Hospira, Inc.’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Hospira, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

The report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles/records featured in the report undergoes periodic updates following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Hospira, Inc. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Hospira, Inc.’s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement
- Latest news and deals relating to the Hospira, Inc.’s pipeline products

Reasons to buy

- Evaluate Hospira, Inc.’s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Hospira, Inc. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Hospira, Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Hospira, Inc. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Hospira, Inc.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Hospira, Inc. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
READ MORE
Note: Product cover images may vary from those shown
2 of 4
List of Tables

List of Figures

Hospira, Inc. Snapshot

Hospira, Inc. Overview

Key Information

Key Facts

Hospira, Inc. - Research and Development Overview

Key Therapeutic Areas

Hospira, Inc. - Pipeline Review

Pipeline Products by Stage of Development

Pipeline Products - Monotherapy

Pipeline Products - Partnered Products

Partnered Products/Combination Treatment Modalities

Hospira, Inc. - Pipeline Products Glance

Hospira, Inc. - Late Stage Pipeline Products

Pre-Registration Products/Combination Treatment Modalities

Phase III Products/Combination Treatment Modalities

Hospira, Inc. - Clinical Stage Pipeline Products

Phase I Products/Combination Treatment Modalities

Hospira, Inc. - Early Stage Pipeline Products

Discovery Products/Combination Treatment Modalities

Hospira, Inc. - Drug Profiles

epoetin zeta

Product Description

Mechanism of Action

R&D Progress

filgrastim

Product Description

Mechanism of Action

R&D Progress

pegfilgrastim

Product Description

Mechanism of Action

R&D Progress

rituximab biosimilar

Product Description

Mechanism of Action

R&D Progress

bevacizumab biosimilar

Product Description

Mechanism of Action

R&D Progress

Hospira, Inc. - Pipeline Analysis

Hospira, Inc. - Pipeline Products by Target

Hospira, Inc. - Pipeline Products by Route of Administration

Hospira, Inc. - Pipeline Products by Molecule Type

Hospira, Inc. - Pipeline Products by Mechanism of Action

Hospira, Inc. - Recent Pipeline Updates

Hospira, Inc. - Dormant Projects

Hospira, Inc. - Discontinued Pipeline Products

Discontinued Pipeline Product Profiles

E-21R

Hospira, Inc. - Company Statement

Hospira, Inc. - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Hospira, Inc. - Key Manufacturing Facilities

Appendix

Methodology

Coverage

Secondary Research

Primary Research

Expert Panel Validation

Contact Us

Disclaimer

List of Tables

Hospira, Inc., Key Information

Hospira, Inc., Key Facts

Hospira, Inc. - Pipeline by Indication, 2015

Hospira, Inc. - Pipeline by Stage of Development, 2015

Hospira, Inc. - Monotherapy Products in Pipeline, 2015

Hospira, Inc. - Partnered Products in Pipeline, 2015

Hospira, Inc. - Partnered Products/ Combination Treatment Modalities, 2015

Hospira, Inc. - Pre-Registration, 2015

Hospira, Inc. - Phase III, 2015

Hospira, Inc. - Phase I, 2015

Hospira, Inc. - Discovery, 2015

Hospira, Inc. - Pipeline by Target, 2015

Hospira, Inc. - Pipeline by Route of Administration, 2015

Hospira, Inc. - Pipeline by Molecule Type, 2015

Hospira, Inc. - Pipeline Products by Mechanism of Action, 2015

Hospira, Inc. - Recent Pipeline Updates, 2015

Hospira, Inc. - Dormant Developmental Projects,2015

Hospira, Inc. - Discontinued Pipeline Products, 2015

Hospira, Inc., Other Locations

Hospira, Inc., Subsidiaries

Hospira, Inc., Key Manufacturing Facilities

List of Figures

Hospira, Inc. - Pipeline by Top 10 Indication, 2015

Hospira, Inc. - Pipeline by Stage of Development, 2015

Hospira, Inc. - Monotherapy Products in Pipeline, 2015

Hospira, Inc. - Partnered Products in Pipeline, 2015

Hospira, Inc. - Pipeline by Top 10 Target, 2015

Hospira, Inc. - Pipeline by Top 10 Route of Administration, 2015

Hospira, Inc. - Pipeline by Top 10 Molecule Type, 2015

Hospira, Inc. - Pipeline Products by Top 10 Mechanism of Action, 2015
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll